CGM Use in Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.

Also called NCT07045298

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07045298
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07045298. Randomized; no masking; primary purpose diagnostic. Start 2026-11 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CGM Use in Heart Failure
Condition
Heart Failure
Condition
Diabetes Mellitus
Intervention (Device)
Libre 2 rt-CGM
Intervention (Diagnostic test)
POC BG + Blinded CGM
Lead sponsor
Emory University (class: other)
Collaborator
American Heart Association (class: other)
Collaborator
Abbott Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct07045298
Content hash
48431772ca0e5b3129e7a59c7ce33619d7a00406bf8257a181ec22f7648da8cd